Design and rationale of the VICTORION-Difference study: A phase 4 randomized, double-blind, placebo-controlled clinical trial to assess inclisiran’s early efficacy, safety, tolerability, as well as its impact on quality of life in individuals with hypercholesterolemia

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 959798dbdb43fac2-LAX IP: 47.97.18.252 UTC time: 2025-07-03T16:00:40+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

View original article

AMERICAN HEART JOURNAL

Like

Share Bookmark

0 0 0 0 0 0 0

More from this channel

Design and rationale of the VICTORION-Difference study: A phase 4 randomized, double-blind, placebo-controlled clinical trial to assess inclisiran’s early efficacy, safety, tolerability, as well as its impact on quality of life in individuals with hypercholesterolemia

Comments (0)